Answers are grounded in this paper and cite their sources.
Today, respiratory diseases are one of the most widespread pathologies of children, causing maximum morbidity. The aim of our study was to determine and analyze differences in clinical and laboratory data and outcomes among children hospitalized with respiratory diseases of COVID-19 and other etiologies. For this purpose, 164 patients under the age of 17 were involved in the study. Patients were divided into two groups: Group I included 89 (54.3%) patients diagnosed with CKD (upper respiratory tract diseases of various etiologies), Group II included 75 (45.7%) patients diagnosed with COVID-19 (PCR positive) pneumonia. During the clinical examination, intoxication, indigestion, auscultatory changes in the lungs, loss of sense of smell, muscle pains, etc., upper respiratory tract damage syndrome, catarrhal symptoms, rhinitis, hyperemia of yawning at various levels during CRX were more manifested during the clinical examination. In both comparison groups of sick children, the main leading symptoms in general were fever 122 (74.4%), cough 133 (81.1%). An increase in the concentration of pro-inflammatory cytokines (IL-1β, IL-6, Il-18) was observed in the blood of patients during both pathologies. Cytokine levels were more prominent increased during COVID-19 compared to ARDs. This indicates the severity of the inflammatory process during COVID-19. The study of the level of pro-inflammatory cytokines in the blood serum of COVID-19 patients allows to determine the progress and severity of the inflammatory process.
No takes yet. Share an insight, caveat, or question.
Qazanfar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: